Prospective T1 mapping to assess gadolinium retention in brain after intrathecal gadobutrol.
Geir RingstadLars Magnus ValnesSvein Are Sirirud VatneholAre Hugo PrippPer Kristian EidePublished in: Neuroradiology (2023)
Gadolinium retention was not detected in the cerebral hemispheres 4 weeks after an intrathecal dose of 0.5 mmol gadobutrol, implying that presence of contrast agents in cerebrospinal fluid is of minor importance for gadolinium retention in brain.